![Gustaf Marcus Friström](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gustaf Marcus Friström
Presidente presso SafeTrach AB
Posizioni attive di Gustaf Marcus Friström
Società | Posizione | Inizio | Fine |
---|---|---|---|
Antrad Medical AB
![]() Antrad Medical AB Medical DistributorsDistribution Services Antrad Medical AB provides thawing frozen blood plasma for hospitals emergency departments. It develops medical devices for thawing and warming of blood plasma. The company’s product Antrad UFT100 provides two bags of thawed ready to use blood plasma. The company is headquartered in Kista, Sweden. | Direttore/Membro del Consiglio | 01/01/2011 | - |
SafeTrach AB
![]() SafeTrach AB Medical SpecialtiesHealth Technology SafeTrach AB provides surgical technology. Its tracheotomy is a temporary or permanent treatment for a variety of causes of breathing difficulties in which the creation of a new breathing pathway is required, by-passing the nose, mouth, and throat. The company was founded by Gregory Margolin and Jonas Karling in 2008 and is headquartered in Sundbyberg, Sweden. | Presidente | - | - |
Storia della carriera di Gustaf Marcus Friström
Statistiche
Distribuzione geografica
Svezia | 3 |
Posizioni
Director/Board Member | 1 |
Chairman | 1 |
Settori
Distribution Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Antrad Medical AB
![]() Antrad Medical AB Medical DistributorsDistribution Services Antrad Medical AB provides thawing frozen blood plasma for hospitals emergency departments. It develops medical devices for thawing and warming of blood plasma. The company’s product Antrad UFT100 provides two bags of thawed ready to use blood plasma. The company is headquartered in Kista, Sweden. | Distribution Services |
SafeTrach AB
![]() SafeTrach AB Medical SpecialtiesHealth Technology SafeTrach AB provides surgical technology. Its tracheotomy is a temporary or permanent treatment for a variety of causes of breathing difficulties in which the creation of a new breathing pathway is required, by-passing the nose, mouth, and throat. The company was founded by Gregory Margolin and Jonas Karling in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |